Source: ALL

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3880
Gene Symbol: KRT19
KRT19
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm 		0.070 AlteredExpression BEFREE In conclusion, the results of the current study suggest that BRAF<sup>V600E</sup>-induced KRT19 expression may promote thyroid cancer metastasis via EMT. 31289571

2019
Entrez Id: 3880
Gene Symbol: KRT19
KRT19
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm 		0.070 Biomarker BEFREE Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer. 28943926

2017
Entrez Id: 3880
Gene Symbol: KRT19
KRT19
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm 		0.070 Biomarker BEFREE The use of galectin-3, HBME-1, and cytokeratin-19 may provide significant contributions in the differential diagnosis of malignant thyroid tumors. 20198455

2010
Entrez Id: 3880
Gene Symbol: KRT19
KRT19
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm 		0.070 Biomarker BEFREE Moreover, qPCR of CK19 is a valid method that could be used as an ancillary tool in diagnosing thyroid cancer. 18308654

2008
Entrez Id: 3880
Gene Symbol: KRT19
KRT19
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm 		0.070 Biomarker BEFREE These were compared with 2 other molecules that have been previously studied in thyroid cancer (cytokeratin-19 and galectin-3). 18261626

2008
Entrez Id: 3880
Gene Symbol: KRT19
KRT19
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm 		0.070 Biomarker LHGDN Circulating cytokeratin 19 fragments in patients with benign nodules and carcinomas of the thyroid gland. 18409152

2008
Entrez Id: 3880
Gene Symbol: KRT19
KRT19
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm 		0.070 Biomarker LHGDN RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation. 15716612

2005